We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+10.92%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$43.9B
AUM Growth
+$2.87B
(+7%)
Cap. Flow
-$890M
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
13.25%
Holding
2,343
New
170
Increased
997
Reduced
1,015
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$111M |
| 2 |
Verizon
VZ
|
+$103M |
| 3 |
AT&T
T
|
+$103M |
| 4 |
Kroger
KR
|
+$97.1M |
| 5 |
3M
MMM
|
+$92.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$138M |
| 2 |
Tesla
TSLA
|
+$110M |
| 3 |
JPMorgan Chase
JPM
|
+$103M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$89.4M |
| 5 |
Apple
AAPL
|
+$85.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 16.25% |
| 3 | Financials | 11.85% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
CenterPoint Energy
CNP
$26.5B
| $8.59M | 0.02% |
286,529
-113,470
| -28% | -$3.3M |
|
702
Johnson Controls International
JCI
$93.7B
| $8.56M | 0.02% |
134,343
-200,615
| -60% | -$12.3M |
|
703
UFP Industries
UFPI
$5.12B
| $8.52M | 0.02% |
107,530
+18,391
| +21% | +$1.4M |
|
704
Polaris
PII
$3.99B
| $8.49M | 0.02% |
85,172
+16,566
| +24% | +$1.73M |
|
705
Horizon Bancorp
HBNC
$1.05B
| $8.47M | 0.02% |
561,832
+330,825
| +143% | +$5.46M |
|
706
Patrick Industries
PATK
$2.81B
| $8.47M | 0.02% |
209,648
+43,652
| +26% | +$1.52M |
|
707
Sabra Healthcare REIT
SBRA
$5.07B
| $8.3M | 0.02% |
670,208
-32,094
| -5% | -$409K |
|
708
Hanmi Financial
HAFC
$948M
| $8.22M | 0.02% |
332,260
-24,001
| -7% | -$611K |
|
709
Blackbaud
BLKB
$2.06B
| $8.22M | 0.02% |
139,594
+49,346
| +55% | +$2.76M |
|
710
ITT
ITT
$19.4B
| $8.21M | 0.02% |
101,493
-56,836
| -36% | -$4.4M |
|
711
Service Corp International
SCI
$11.4B
| $8.17M | 0.02% |
118,214
-97,291
| -45% | -$6.48M |
|
712
Ironwood Pharmaceuticals
IRWD
$711M
| $8.17M | 0.02% |
659,197
+82,809
| +14% | +$939K |
|
713
Carter's
CRI
$1.46B
| $8.13M | 0.02% |
108,941
-9,800
| -8% | -$702K |
|
|
TPC
714
Tutor Perini Cor
TPC
$5.13B
| $8.12M | 0.02% |
1,075,062
+284,950
| +36% | +$2.02M |
|
715
Post Holdings
POST
$3.56B
| $8.1M | 0.02% |
90,108
-32,023
| -26% | -$2.85M |
|
716
Coca-Cola Femsa
KOF
$23B
| $8.09M | 0.02% |
119,190
-5,661
| -5% | -$369K |
|
717
CubeSmart
CUBE
$9.2B
| $8.06M | 0.02% |
200,333
-186,930
| -48% | -$7.52M |
|
718
PG&E
PCG
$38.1B
| $7.98M | 0.02% |
491,359
-108,570
| -18% | -$1.64M |
|
719
Genco Shipping & Trading
GNK
$1.08B
| $7.96M | 0.02% |
518,121
+146,355
| +39% | +$2.12M |
|
720
Manitowoc
MTW
$702M
| $7.94M | 0.02% |
866,970
+256,797
| +42% | +$2.34M |
|
721
Realty Income
O
$58.6B
| $7.92M | 0.02% |
124,926
-3,878
| -3% | -$241K |
|
722
Sinclair Inc
SBGI
$989M
| $7.92M | 0.02% |
531,246
+195,121
| +58% | +$3.47M |
|
723
Prudential Financial
PRU
$42.2B
| $7.91M | 0.02% |
79,515
-197,836
| -71% | -$20M |
|
724
Lennox International
LII
$14.9B
| $7.89M | 0.02% |
33,031
-100,440
| -75% | -$24.6M |
|
725
Welltower
WELL
$163B
| $7.82M | 0.02% |
119,332
-2,487
| -2% | -$160K |
|
Similar funds
VGA
AQR Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, AQR Capital Management held 2,343 positions worth $43.9B, up 7% from $41B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management's Q4 2022 filing shows 170 new, 997 increased, 1,015 reduced and 150 closed positions. Its largest new stake was Generac Holdings: 310,080 shares worth $30.5M. The largest sale was Gilead Sciences, an estimated $138M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q4 2022 buy was Generac Holdings: 310,080 shares worth $30.5M.
- AQR Capital Management added most to Humana in Q4 2022, an estimated $111M increase.
- AQR Capital Management's biggest Q4 2022 reduction was Gilead Sciences, cutting an estimated $138M.
- AQR Capital Management fully exited Abiomed Inc in Q4 2022, selling an estimated $22.4M.
- AQR Capital Management's ten largest holdings make up 13% of its $43.9B portfolio in Q4 2022.
- AQR Capital Management opened 170 new positions and closed 150 in Q4 2022.
- AQR Capital Management's portfolio value rose 7% quarter-over-quarter to $43.9B.
Based on AQR Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.